PATENT CLAIM ANALYSIS

Application Number: 15895279
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["514", "207000"]

Abstract:
Pharmaceutical compositions are provided in unit dosage forms comprising ceftolozane and tazobactam in separate unit dosage form containers, ceftolozane prepared in the absence of tazobactam, tazobactam prepared in the absence of ceftolozane, and/or compositions where ceftolozane and tazobactam are first combined within a unit dosage form container.

Claim (Index 8):
A unit dosage form package comprising a unit dosage form container enclosing a ceftolozane composition obtained by a process comprising the steps of\n a. forming a solution comprising an amount of ceftolozane sulfate providing 1,000 mg of ceftolozane active, 125-500 mg sodium chloride, about 500 mg tazobactam acid, sodium bicarbonate and L-arginine at a pH of about 5-7 within a unit dosage form container b. lyophilizing the solution within the unit dosage form container to obtain a co-lyophilized composition; and c. enclosing the co-lyophilized composition within the unit dosage form container, wherein the co-lyophilized composition further comprises about 0.03%-1.0% of a compound of formula (III) upon lyophilization:

Metadata:
- Claim Count in Document: 11.0
- Percentile: 88.0
- Lexical Diversity: 1.82143
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15071530', '14214221', '14285185', '15844961', '14856075']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7931223811122451
- 35 USC 102 Novelty (BERT): 0.6214836033498109
- Combined Prediction Score: 0.7759585033360017
- Mean Citation Score: 540.2332100000001
- Max Citation Score: 644.7732
- Similarity Product: 487.88314940385817

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test